Inverted triangle to appear on EU medicines requiring special monitoring

10/2/2013 | PMLive.com (U.K.)

Medicines in the EU that require special monitoring must now carry an inverted black triangle and accompanying warning label. The triangle does not indicate that the drug is unsafe, but rather that it requires careful oversight because it contains a new active ingredient or is subject to further studies. The triangle reminds health professionals and patients to report any suspected adverse effects from the medication.

View Full Article in:

PMLive.com (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX